for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

CVS Health Corp

CVS.N

Latest Trade

74.12USD

Change

0.04(+0.05%)

Volume

1,203,930

Today's Range

73.03

 - 

74.30

52 Week Range

52.04

 - 

77.22

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Cvs Health Provides Update On Covid-19 Vaccinations In Long-Term Care Facilities

Jan 6 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH PROVIDES UPDATE ON COVID-19 VACCINATIONS IN LONG-TERM CARE FACILITIES.CVS HEALTH CORP - ADMINISTERING COVID-19 VACCINES IN SKILLED NURSING FACILITIES IN 49 STATES.CVS HEALTH CORP - ACTIVATION DATES AT REMAINING NEARLY 8,000 CVS HEALTH PARTNER FACILITIES HAVE YET TO BE DETERMINED BY STATES.CVS HEALTH- PER AGREEMENT WITH DEPARTMENT OF HEALTH AND HUMAN RESOURCES, COVID-19 VACCINES WILL EVENTUALLY BE AVAILABLE AT ALL CVS PHARMACY LOCATIONS.CVS HEALTH CORP - EXPECTS TO COMPLETE ADMINISTRATION OF COVID-19 VACCINE FIRST DOSES IN SKILLED NURSING FACILITIES BY JANUARY 25.CVS HEALTH CORP - CVS PHARMACY HAS CAPACITY TO ADMINISTER 20 - 25 MILLION SHOTS PER MONTH.

Cvs Health Sets Quarterly Dividend Of $0.50 Per Share

Jan 4 (Reuters) - CVS Health Corp <CVS.N>::SETS QUARTERLY DIVIDEND OF $0.50PER SHARE.

CVS Health Begins Administering Covid-19 Vaccines In Long-Term Care Facilities

Dec 21 (Reuters) - :CVS HEALTH BEGINS ADMINISTERING COVID-19 VACCINES IN LONG-TERM CARE FACILITIES.CVS HEALTH - EXPECTS TO VACCINATE UP TO 4 MILLION RESIDENTS AND STAFF AT OVER 40,000 LONG-TERM CARE FACILITIES THROUGH PROGRAM.CVS HEALTH - WILL ADMINISTER THE FIRST DOSE OF THE PFIZER VACCINE IN FACILITIES ACROSS 12 STATES THIS WEEK.CVS HEALTH - EXPECTS TO COMPLETE ITS LONG-TERM CARE FACILITY VACCINATION EFFORT IN ABOUT 12 WEEKS.

Cvs Health Corp Files Prospectus Supplement For $750 Million 1.3% Senior Notes Due 2027 And $1.25 Billion 1.875% Senior Notes Due 2031

Dec 9 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH CORP FILES PROSPECTUS SUPPLEMENT FOR $750 MILLION 1.300% SENIOR NOTES DUE 2027 AND $1.25 BILLION 1.875% SENIOR NOTES DUE 2031 - SEC FILING.

Cvs Health Corp Says CEO Lynch Will Receive Annualized Base Salary Of $1.45 Million

Nov 6 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH CORP - CEO LYNCH WILL RECEIVE ANNUALIZED BASE SALARY OF $1.45 MILLION.

CVS Health Reports Q3 Adjusted Earnings Per Share Of $1.66

Nov 6 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH REPORTS THIRD QUARTER RESULTS WITH DIVERSIFIED ASSETS DELIVERING STRONG ENTERPRISE PERFORMANCE.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $7.35 TO $7.45.SEES FY 2020 GAAP EARNINGS PER SHARE $5.60 TO $5.70.Q3 ADJUSTED EARNINGS PER SHARE $1.66.Q3 GAAP EARNINGS PER SHARE $0.93.Q3 EARNINGS PER SHARE ESTIMATE $1.33 -- REFINITIV IBES DATA.2020 FULL YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE RANGES RAISED.QTRLY TOTAL REVENUES INCREASED TO $67.1 BILLION, UP 3.5%.DOUBLED NUMBER OF TEST SITES TO MORE THAN 4,000 CVS PHARMACY LOCATIONS NATIONWIDE.Q3 REVENUE VIEW $66.66 BILLION -- REFINITIV IBES DATA.RAISED 2020 CASH FLOW FROM OPERATIONS GUIDANCE RANGE TO $12.75 BILLION TO $13.25 BILLION.QTRLY TOTAL SAME STORE SALES ROSE 5.7%.ADMINISTERED MORE THAN SIX MILLION COVID-19 TESTS NATIONWIDE TO DATE.QTRLY PHARAMCY SAME STORE SALES ROSE 6.7%; FRONT STORE SAME STORE SALES ROSE 2.2%.FY2020 EARNINGS PER SHARE VIEW $7.24 -- REFINITIV IBES DATA.SAW INCREASED DIAGNOSTIC TESTING IN RESPONSE TO THE COVID-19 PANDEMIC IN QUARTER.CVS HEALTH - DUE TO PANDEMIC, IN QUARTER, SAW REDUCED NEW THERAPY PRESCRIPTIONS, IN FRONT STORE SAW DECREASED CUSTOMER TRAFFIC IN RETAIL PHARMACIES.

CVS Health Says To Date, Has Administered More Than 5 Million Covid-19 Tests Since March

Oct 28 (Reuters) - CVS Health::CVS HEALTH EXPANDS COVID-19 TESTING SERVICES WITH PLANS TO ADD NEARLY 1,000 RAPID-RESULT TEST SITES AT SELECT CVS PHARMACY LOCATIONS BY YEAR END.CVS HEALTH - TO DATE, CO ADMINISTERED MORE THAN 5 MILLION COVID-19 TESTS SINCE MARCH.

Cvs Health- Has Approved A Quarterly Dividend Of $0.50 Per Share On Co's Common Stock

Oct 7 (Reuters) - CVS Health Corp <CVS.N>::CVS HEALTH CORP - HAS APPROVED A QUARTERLY DIVIDEND OF $0.50 PER SHARE ON CO'S COMMON STOCK.

CVS Health Corp Says To Revise Full Year 2020 GAAP Diluted Earnings Per Share Guidance Range

Sept 15 (Reuters) - CVS Health Corp <CVS.N>::TO REVISE FULL YEAR 2020 GAAP DILUTED EARNINGS PER SHARE GUIDANCE RANGE TO $5.16 TO $5.29 FROM $5.59 TO $5.72.TO MAINTAIN PREVIOUSLY ANNOUNCED FULL YEAR 2020 ADJUSTED EPS GUIDANCE RANGE.TO MAINTAIN PREVIOUSLY ANNOUNCED FY 2020 CASH FLOW FROM OPERATIONS GUIDANCE RANGE.FY2020 EARNINGS PER SHARE VIEW $7.23 -- REFINITIV IBES DATA.

West Virginia Attorney General Patrick Morrisey Says Filed Lawsuits Against Walmart And CVS

Aug 18 (Reuters) - WEST VIRGINIA ATTORNEY GENERAL::WEST VIRGINIA ATTORNEY GENERAL PATRICK MORRISEY SAYS FILED LAWSUITS TUESDAY AGAINST WALMART AND CVS.AG MORRISEY SAYS LAWSUITS ALLEGE WALMART, CVS SUPPLIED FAR MORE OPIOIDS TO THEIR RETAIL PHARMACIES THAN NECESSARY TO MEET A LEGITIMATE MARKET.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up